181 related articles for article (PubMed ID: 32315192)
1. Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid.
Batruch I; Lim B; Soosaipillai A; Brinc D; Fiala C; Diamandis EP
J Proteome Res; 2020 Aug; 19(8):3060-3071. PubMed ID: 32315192
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
3. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
4. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
5. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
6. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
7. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
8. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
9. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
10. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
11. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
12. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
Voehringer P; Fuertig R; Ferger B
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
[TBL] [Abstract][Full Text] [Related]
13. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
Ziganshin RH; Kovalchuk SI; Azarkin IV
Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
16. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
17. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
18. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.
Mouton-Barbosa E; Roux-Dalvai F; Bouyssié D; Berger F; Schmidt E; Righetti PG; Guerrier L; Boschetti E; Burlet-Schiltz O; Monsarrat B; Gonzalez de Peredo A
Mol Cell Proteomics; 2010 May; 9(5):1006-21. PubMed ID: 20093276
[TBL] [Abstract][Full Text] [Related]
19. A rapid method for preparation of the cerebrospinal fluid proteome.
Larssen E; Brede C; Hjelle AB; Øysaed KB; Tjensvoll AB; Omdal R; Ruoff P
Proteomics; 2015 Jan; 15(1):10-5. PubMed ID: 25307358
[TBL] [Abstract][Full Text] [Related]
20. Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.
Begcevic I; Brinc D; Drabovich AP; Batruch I; Diamandis EP
Clin Proteomics; 2016; 13():11. PubMed ID: 27186164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
